InterventionsReview

Glucagon-Like Peptide 1 Receptor Agonists for Antipsychotic-Associated Metabolic Dysfunctions In Patients with Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

ADA Scientific Sessions 2026 Abstract

The paper

SRIVASTAVA J, SINHA V, ABREU M et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2870-LB

doi.org/10.2337/db26-2870-lb

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026